|
1
|
Rodon J, Carducci MA, Sepulveda-Sánchez
JM, Azaro A, Calvo E, Seoane J, Braña I, Sicart E, Gueorguieva I,
Cleverly AL, et al: First-in-human dose study of the novel
transforming growth factor-β receptor I kinase inhibitor LY2157299
monohydrate in patients with advanced cancer and glioma. Clin
Cancer Res. 21:553–560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peters KB, West MJ, Hornsby WE, Waner E,
Coan AD, McSherry F, JE II Herndon, Friedman HS, Desjardins A and
Jones LW: Impact of health-related quality of life and fatigue on
survival of recurrent high-grade glioma patients. J Neurooncol.
120:499–506. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu H, Lv Z and Guo E: Knockdown of long
noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation,
metastasis and epithelial-mesenchymal transition. Int J Clin Exp
Pathol. 8:9140–9146. 2015.PubMed/NCBI
|
|
4
|
Chen XH, Ling XM and Shi S: microRNA-106a
induces the proliferation and apoptosis of glioma cells through
regulating JNK/MAPK pathway. Eur Rev Med Pharmacol Sci.
19:3412–3417. 2015.PubMed/NCBI
|
|
5
|
Kwiatkowska A and Symons M: Signaling
determinants of glioma cell invasion. Adv Exp Med Biol.
986:121–141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Havens AM, Jung Y, Sun YX, Wang J, Shah
RB, Bühring HJ, Pienta KJ and Taichman RS: The role of sialomucin
CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC
Cancer. 6:1952006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Darash-Yahana M, Pikarsky E, Abramovitch
R, Zeira E, Pal B, Karplus R, Beider K, Avniel S, Kasem S, Galun E
and Peled A: Role of high expression levels of CXCR4 in tumor
growth, vascularization and metastasis. FASEB J. 18:1240–1242.
2004.PubMed/NCBI
|
|
8
|
Tabaczar S, Domeradzka K, Czepas J,
Piasecka-Zelga J, Stetkiewicz J, Gwoździński K and Koceva-Chyła A:
Anti-tumor potential of nitroxyl derivative Pirolin in the
DMBA-induced rat mammary carcinoma model: A comparison with
quercetin. Pharmacol Rep. 67:527–534. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murad N, Kokkinaki M, Gunawardena N,
Gunawan MS, Hathout Y, Janczura KJ, Theos AC and Golestaneh N:
miR-184 regulates ezrin, LAMP-1 expression, affects phagocytosis in
human retinal pigment epithelium and is downregulated in
age-related macular degeneration. FEBS J. 281:5251–5264. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Forde S, Tye BJ, Newey SE, Roubelakis M,
Smythe J, McGuckin CP, Pettengell R and Watt SM: Endolyn (CD164)
modulates the CXCL12-mediated migration of umbilical cord blood
CD133+ cells. Blood. 109:1825–1833. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Doyonnas R, Yi-Hsin Chan J, Butler LH,
Rappold I, Lee-Prudhoe JE, Zannettino AC, Simmons PJ, Bühring HJ,
Levesque JP and Watt SM: CD164 monoclonal antibodies that block
hemopoietic progenitor cell adhesion and proliferation interact
with thefirst mucin domain of the CD164 receptor. J Immunol.
165:840–851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jorgensen-Tye B, Levesque JP, Royle L,
Doyonnas R, Chan JY, Dwek RA, Rudd PM, Harvey DJ, Simmons PJ and
Watt SM: Epitope recognition of antibodies that define the
sialomucin, endolyn (CD164), a negative regulator of
haematopoiesis. Tissue Antigens. 65:220–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin J, Xu K, Wei J, Heimberger AB, Roth JA
and Ji L: MicroRNA-124 suppresses tumor cell proliferation and
invasion by targeting CD164 signaling pathway in non-small cell
lung cance. J Gene Ther. 2:62016.PubMed/NCBI
|
|
14
|
Shi JA, Lu DL, Huang X and Tan W: miR-219
inhibits the proliferation, migration and invasion of
medulloblastoma cells by targeting CD164. Int J Mol Med.
34:237–243. 2014.PubMed/NCBI
|
|
15
|
Tang J, Zhang L, She X, Zhou G, Yu F,
Xiang J and Li G: Inhibiting CD164 expression in colon cancer cell
line HCT116 leads to reduced cancer cell proliferation, mobility,
and metastasis in vitro and in vivo. Cancer Invest. 30:380–389.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Havens AM, Jung Y, Sun YX, Wang J, Shah
RB, Bühring HJ, Pienta KJ and Taichman RS: He role of sialomucin
CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC
Cancer. 6:1952006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Coustan-Smith E, Song G, Clark C, Key L,
Liu P, Mehrpooya M, Stow P, Su X, Shurtleff S, Pui CH, et al: New
markers for minimal residual disease detection in acute
lymphoblastic leukemia. Blood. 117:6267–6676. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chirumbolo S: CD164 and other recently
discovered activation markers as promising tools for allergy
diagnosis: What's new? Clin Exp Med. 11:255–257. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang AF, Chen MW, Huang SM, Kao CL, Lai
HC and Chan JY: CD164 regulates the tumorigenesis of ovarian
surface epithelial cells through the SDF-1α/CXCR4 axis. Mol Cancer.
12:1152013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kordezangeneh M, Irani S, Mirfakhraie R,
Esfandyari-Manesh M, Atyabi F and Dinarvand R: Regulation of
BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded
human serum albumin nanoparticles. Med Oncol. 32:2082015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rodríguez-Berriguete G, Torrealba N,
Ortega MA, Martínez-Onsurbe P, Olmedilla G, Paniagua R, Guil-Cid M,
Fraile B and Royuela M: Prognostic value of inhibitors of apoptosis
proteins (IAPs) and caspases in prostate cancer: Caspase-3 forms
and XIAP predict biochemical progression after radical
prostatectomy. BMC Cancer. 15:8092015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shang Y, Guo XX, Li WW, Rao W, Chen ML, Mu
LN and Li SJ: Cucurbitacin-B inhibits neuroblastoma cell
proliferation through up-regulation of PTEN. Eur Rev Med Pharmacol
Sci. 18:3297–3303. 2014.PubMed/NCBI
|
|
24
|
Li XT, Wang HZ, Wu ZW, Yang TQ, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Huang YL, et al: miR-494-3p
regulates cellular proliferation, invasion, migration and apoptosis
by PTEN/AKT signaling in human glioblastoma cells. Cell Mol
Neurobiol. 35:679–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma Q, Zhang Y, Meng R, Xie KM, Xiong Y,
Lin S, He ZL, Tao T, Yang Y, Zhao JZ and He JQ: MAGI3 suppresses
glioma cell proliferation via upregulation of PTEN expression.
Biomed Environ Sci. 28:502–509. 2015.PubMed/NCBI
|
|
26
|
Wang LJ, He CC, Sui X, Cai MJ, Zhou CY, Ma
JL, Wu L, Wang H, Han SX and Zhu Q: MiR-21 promotes intrahepatic
cholangiocarcinoma proliferation and growth in vitro and in vivo by
targeting PTPN14 and PTEN. Oncotarget. 6:5932–5946. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang WR, Chiu HC, Liao TL, Chuang KP,
Shih WL and Liu HJ: Correction: avian reovirus protein p17
functions as a nucleoporin Tpr suppressor Leading to activation of
p53, p21 and PTEN and inactivation of PI3K/AKT/mTOR and ERK
signaling pathways. PLoS One. 10:e01386272015. View Article : Google Scholar : PubMed/NCBI
|
